Literature DB >> 9415702

Molecular cloning and expression of an avian G protein-coupled P2Y receptor.

J L Boyer1, G L Waldo, T K Harden.   

Abstract

A family of G protein-coupled P2Y receptors that are activated by adenine and uridine nucleotides has been identified recently. Degenerate primers based on conserved sequences in these P2Y receptors were used to amplify turkey DNA, which was used to isolate the complete coding sequence of a cDNA that encodes a novel G protein-coupled receptor. Stable expression of this avian cDNA in 1321N1 human astrocytoma cells resulted in the conveyance of marked inositol phosphate responses to various nucleotides. Although this cloned avian receptor exhibited its highest homology to the previously cloned mammalian P2Y4 receptor, its pharmacological selectivity was not consistent with the avian receptor's being a species homologue of the P2Y4 receptor. That is, whereas the P2Y4 receptor is selectively activated by UTP and is not activated by ATP or Ap4A, the novel avian receptor was potently activated by ATP and Ap4A as well as by UTP. Taken together, these results describe the identification of an avian phospholipase C-coupled P2Y receptor that, like the mammalian P2Y2 receptor, is activated by both adenine and uridine nucleotides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415702     DOI: 10.1124/mol.52.6.928

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

1.  Nucleotide-mediated relaxation in guinea-pig aorta: selective inhibition by MRS2179.

Authors:  Robert A Kaiser; Iain L O Buxton
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors.

Authors:  Dayle Houston; Michihiro Ohno; Robert A Nicholas; Kenneth A Jacobson; T Kendall Harden
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

3.  Quantitation of extracellular UTP using a sensitive enzymatic assay.

Authors:  E R Lazarowski; T K Harden
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 4.  P2 receptor subtypes in the cardiovascular system.

Authors:  S P Kunapuli; J L Daniel
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

5.  Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase.

Authors:  A D Qi; C Kennedy; T K Harden; R A Nicholas
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  Functional expression of a cDNA encoding a human ecto-ATPase.

Authors:  J Mateo; T K Harden; J L Boyer
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

7.  Transformation by a nucleotide-activated P2Y receptor is mediated by activation of Galphai, Galphaq and Rho-dependent signaling pathways.

Authors:  Anurag Singh; José L Boyer; Channing J Der; Irene E Zohn
Journal:  J Mol Signal       Date:  2010-07-23

8.  Delineation of ligand binding and receptor signaling activities of purified P2Y receptors reconstituted with heterotrimeric G proteins.

Authors:  Erik T Bodor; Gary L Waldo; Rainer Blaesius; T Kendall Harden
Journal:  Purinergic Signal       Date:  2004-12       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.